David Hollander - 11 Nov 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role
Chief R&D Officer
Signature
/s/ John LaRocca, Attorney-in-Fact for David Hollander
Issuer symbol
N/A
Transactions as of
11 Nov 2021
Net transactions value
-$26,074
Form type
4
Filing time
15 Nov 2021, 15:44:11 UTC
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Tax liability $26,074 -2,162 -6.4% $12.06 31,676 11 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.